Skip to main content

Table 5 Recommendations to promote adoption of NGS in clinical oncology

From: Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

Domain Recommendation
Social ▪ Further investigate patients’ perspective
▪ Organize additional training on pharmacogenomics for physicians.
Technical ▪ Use desired technical specifications as a guideline for development of a NGS panel.
▪ Develop user-friendly FFPE-capable NGS panels.
Reimbursement ▪ Further investigate willingness-to-pay
▪ Set cost-effectiveness as a high priority to facilitate reimbursement.
Clinical utility and evidence generation ▪ Advocate novel evidence generation designs.
Market access ▪ Enter the market rapidly to maximize window of opportunity
  1. FFPE fresh frozen paraffin embedded [tissue preservation]